MIRA

시장 영업 전: 1.25 0.08 +6.84%

Mira Pharmaceuticals Inc (MIRA)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Mira Pharmaceuticals Inc

Healthcare (1176)

813-369-5150

1200 BRICKELL AVENUE, MIAMI

최신 SEC 제출 서류

MIRA's Discussions on Twitter

MIRA을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
MIRA Mira Pharmaceuticals Inc	1.17	19.38M	0	-12.78M	-4.71M	-0.8815
LLY Lilly Eli Co	742.35	705.53B	40.86B	8.37B	-2.28B	9.25
NVO Novo Nordisk Adr	81.03	359.79B	39.36B	13.79B	9.83B	3.086
JNJ Johnson Johnson	148.15	344.63B	87.70B	14.68B	19.03B	6.05
ABBV Abbvie Inc	172.61	305.03B	55.53B	5.12B	15.62B	2.88
MRK Merck Co Inc	96.24	251.88B	63.17B	12.15B	14.84B	4.77

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

Mira Pharmaceuticals Inc (MIRA) 재무 분석

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

MIRA을(를) 다른 주식과 비교

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World

AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance

Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World

Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa

Mira Pharmaceuticals appoints new accounting firm - Investing.com

Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart

StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart

Should You Buy Joby Aviation Stock While It's Below $10? - Barchart

C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart

Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart

2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart

Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart

MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart

MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World

Stocks In Play: Canacol Energy Ltd. - Barchart

Grain Spreads: Profit Taking Theme - Barchart

Stocks Rally On Dovish PCE Inflation Report - Barchart

The Current State Of HR Is Unacceptable - Barchart

Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart

Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart

Is W.R. Berkley Stock Outperforming The Dow? - Barchart

PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart

US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart

Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart

Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart

Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart

Is PPG Industries Stock Underperforming The S&P 500? - Barchart

Stocks Regain Footing On Dovish PCE Inflation Report - Barchart

Enterprise Products Stock Rises 25% YTD: Should You Buy Now Or Avoid It? - Barchart

Three Reasons Why PESI Is Risky And One Stock To Buy Instead - Barchart

SCARBOROUGH INNOVATES PARTNERS WITH SUNRAY VENTURE CAPITAL TO ACCELERATE LOCAL STARTUPS WITH 'CATALYST IGNITE' - Barchart

Knightscope K7 Alpha Testing Underway And 2024 Recap - Barchart

Take-Two (NASDAQ:TTWO): Strongest Q3 Results From The Video Gaming Group - Barchart

Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown - Barchart

Q3 Video Conferencing Earnings: Five9 (NASDAQ:FIVN) Earns Top Marks - Barchart

3 Reasons To Sell BALY And 1 Stock To Buy Instead - Barchart

Rude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart

Crude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart

2025 Picks: 2 Stocks To Buy Now For 50% Upside - Barchart

Three Reasons Why GPRO Is Risky And One Stock To Buy Instead - Barchart

Beyond Reality: Investing In AR/VR Tech For Future Gains - Barchart

Federal Reserve's Preferred Inflation Gauge Shows Price Pressures Eased Last Month - Barchart

The number of Americans applying for unemployment benefits falls significantly after last week's big jump - Barchart

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - AccessWire

MIRA Pharmaceuticals Submits FDA Application for Breakthrough Pain Treatment Targeting $3.1B Market - StockTitan

3 Best Industrials Sector Picks For Long-Term Investors In 2025 - Barchart

EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment - Benzinga

US stocks fall sharply and Dow tumbles 1,100 points after the Fed hints at just 2 rate cuts for 2025 - Barchart

OUTFRONT Media Stock Rises 33% In 6 Months: Will The Trend Last? - Barchart

Mira Pharmaceuticals Inc (MIRA) 재무 분석

매출

순이익

현금흐름

주당 순 이익

MIRA과 유사한 종목